Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1989 2
1990 5
1991 7
1992 4
1993 2
1996 2
1997 2
1998 1
1999 1
2000 1
2001 1
2003 3
2004 1
2005 1
2006 2
2009 6
2010 3
2011 2
2012 4
2013 7
2014 9
2015 6
2016 10
2017 9
2018 7
2019 8
2020 9
2021 6
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. King B, et al. N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26. N Engl J Med. 2022. PMID: 35334197 Clinical Trial.
Acne in adolescents.
Gebauer K. Gebauer K. Aust Fam Physician. 2017 Dec;46(12):892-895. Aust Fam Physician. 2017. PMID: 29464224 Free article. Review.
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
Acne variants.
Gebauer K. Gebauer K. Am J Clin Dermatol. 2000 May-Jun;1(3):187-9. doi: 10.2165/00128071-200001030-00006. Am J Clin Dermatol. 2000. PMID: 12094771 No abstract available.
5-Fluorouracil-induced pseudoporphyria.
Laidman PJ, Gebauer K, Trotter J. Laidman PJ, et al. Among authors: gebauer k. Aust N Z J Med. 1992 Aug;22(4):385. doi: 10.1111/j.1445-5994.1992.tb02154.x. Aust N Z J Med. 1992. PMID: 1359863 No abstract available.
Non-infectious skin disease in Indigenous Australians.
Heyes C, Tait C, Toholka R, Gebauer K. Heyes C, et al. Among authors: gebauer k. Australas J Dermatol. 2014 Aug;55(3):176-84. doi: 10.1111/ajd.12106. Epub 2013 Oct 8. Australas J Dermatol. 2014. PMID: 25117159 Review.
Psoriasis and infection. A clinical practice narrative.
Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J, Wong LC. Rademaker M, et al. Among authors: gebauer k. Australas J Dermatol. 2019 May;60(2):91-98. doi: 10.1111/ajd.12895. Epub 2018 Aug 5. Australas J Dermatol. 2019. PMID: 30079566 Review.
Psoriasis and cancer. An Australian/New Zealand narrative.
Rademaker M, Rubel DM, Agnew K, Andrews M, Armour KS, Baker C, Foley P, Gebauer K, Goh MS, Gupta M, Marshman G, Prince HM, Sullivan J. Rademaker M, et al. Among authors: gebauer k. Australas J Dermatol. 2019 Feb;60(1):12-18. doi: 10.1111/ajd.12889. Epub 2018 Jul 10. Australas J Dermatol. 2019. PMID: 29992535 Free article. Review.
113 results